MEDORL
ActiveSummary
For MEDORL, at least two filing cycles of the annual accounts are missing. The 2022 annual accounts show equity of €561,113 and a net result of -€137,248. Equity is growing by ~10.4% per year across the filed fiscal years. Its solvency ranks better than 30% of 1899 sector peers (fiscal year 2022). The company has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
No current score
Figures too old
The available figures for FY 2022 are too old to assess current financial health.
Filing: At least two filing cycles are missing
Axes, FY 2022 · tick = 2021
Profitability30▼-59
Solvency68▼-11
Growth46▼-21
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2022Solvency, return and age of the figures
Solvency
42.9%
Return on assets
-10.5%
Age of the figures
45 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2023, 3 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 9 filingsPosition against the passed deadline
31-12-2023 close31-07-2024 deadline30-09-2026 today
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2022 was due by 31-07-2023 and was filed on 18-12-2023, 140 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 9 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
140 d late
2021
141 d late
2019
146 d late
2018
153 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 4 accounts on average 145 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2022, abbreviated schema
Turnover
€616,959▼ 12.1%
2021 · €701,558
EBIT margin
-15.8%▼ 47.2pp
2021 · 31.4%
Net result
-€137,248
2021 · €148,052
Working capital
€271,565
2021 · -€136,229
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line2018201920212022
Turnover€621,537-€573,812▼ 7.7%€701,558-€616,959▼ 12.1%
Operating result€166,115-€153,705▼ 7.5%€220,368--€97,529
Net result€111,912-€91,987▼ 17.8%€148,052above the sector's middle half--€137,248below the sector's middle half
EBIT margin26.7%-26.8%▲ 0.1pp31.4%--15.8%▼ 47.2pp
Equity€441,315-€533,302▲ 20.8%€700,773above the sector's middle half-€561,113within the sector's middle half▼ 19.9%
Total assets€1.4m-€1.4m▲ 1.2%€1.3mwithin the sector's middle half-€1.3mwithin the sector's middle half▲ 1.5%
Debt€938,646-€863,685▼ 8.0%€588,155-€746,780▲ 27.0%
Working capital-€7,461-€9,901-€136,229below the sector's middle half-€271,565within the sector's middle half
Solvency32.0%-38.2%▲ 6.2pp54.4%within the sector's middle half-42.9%within the sector's middle half▼ 11.5pp
Current ratio0.98-1.02▲ 0.040.68below the sector's middle half-1.65within the sector's middle half▲ 0.97
Return on assets (ROA)8.1%-6.6%▼ 1.5pp11.5%within the sector's middle half--10.5%below the sector's middle half▼ 22.0pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2022: a loss of €97,529 after €220,368 in 2021, the lowest result in the available series.
Balance-sheet composition
2022 in colour, 2021 as the grey bar beneath
Assets €1.3m
Fixed assets
€617,188 ▼ 38.5%
Current assets
€690,706 ▲ 142%
Equity and liabilities €1.3m
Equity
€561,113 ▼ 19.9%
Debt
€746,780 ▲ 27.0%
Debt's share of the balance-sheet total rises from 45.6% to 57.1%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€43,838▼
2021 · €362,495
Cash flow
€4,119▼
2021 · €290,179
Debt to equity
1.33▲
2021 · 0.84
ROE
-24.5%▼
2021 · 21.1%
Interest coverage
1.86▼
2021 · 13.01
Debt ≤ 1 year
€419,141▼
2021 · €421,240
Debt > 1 year
€327,640▲
2021 · €166,915
Income taxes
€18,442▼
2021 · €47,446
Staff costs
€16,973▲
2021 · €2,806
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2018 | 2019 | 2021 | 2022 | Change |
|---|---|---|---|---|---|
| Turnover70 | €621,537 | €573,812 | €701,558 | €616,959 | ▼ 12.1% |
| Goods, raw materials, services and sundry goods60/61 | - | - | €329,817 | €546,415 | ▲ 65.7% |
| Remuneration, social security and pensions62 | - | - | €2,806 | €16,973 | ▲ 505% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €139,393 | €141,373 | €142,127 | €141,367 | ▼ 0.5% |
| Other operating charges640/8 | - | - | €6,440 | €9,733 | ▲ 51.1% |
| Gross operating margin9900 | €309,623 | €301,372 | €371,741 | €70,544 | ▼ 81.0% |
| Operating profit (loss)9901 | €166,115 | €153,705 | €220,368 | -€97,529 | ▼ 144% |
| Financial income75/76B | - | - | €2,983 | €2,481 | ▼ 16.8% |
| Recurring financial income75 | €95 | €169 | €2,983 | €2,481 | ▼ 16.8% |
| Financial charges65/66B | - | - | €27,853 | €23,519 | ▼ 15.6% |
| Recurring financial charges65 | €28,666 | €52,574 | €27,853 | €23,519 | ▼ 15.6% |
| Profit (loss) for the period before taxes9903 | €137,545 | €101,300 | €195,498 | -€118,567 | ▼ 161% |
| Transfer to deferred taxes680 | - | - | - | €240 | - |
| Income taxes67/77 | €25,633 | €9,313 | €47,446 | €18,442 | ▼ 61.1% |
| Profit (loss) for the period9904 | €111,912 | €91,987 | €148,052 | -€137,248 | ▼ 193% |
| Profit (loss) for the period to be appropriated9905 | €111,912 | €91,987 | €148,052 | -€137,248 | ▼ 193% |
| Line | 2018 | 2019 | 2021 | 2022 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €1.4m | €1.4m | €1.3m | €1.3m | ▲ 1.5% |
| Fixed assets21/28 | €991,132 | €912,122 | €1.0m | €617,188 | ▼ 38.5% |
| Intangible fixed assets21 | €1 | €1 | €1 | €1 | ▼ 2.0% |
| Tangible fixed assets22/27 | €766,360 | €647,351 | €688,280 | €617,087 | ▼ 10.3% |
| Land and buildings22 | - | - | €635,054 | €567,682 | ▼ 10.6% |
| Plant, machinery and equipment23 | - | - | €38,091 | €27,623 | ▼ 27.5% |
| Furniture and vehicles24 | - | - | €15,135 | €21,782 | ▲ 43.9% |
| Financial fixed assets28 | €224,771 | €264,771 | €315,636 | €100 | ▼ 100.0% |
| Current assets29/58 | €388,829 | €484,865 | €285,011 | €690,706 | ▲ 142% |
| Amounts receivable within one year40/41 | €26,098 | €81,098 | - | - | - |
| Current investments50/53 | - | - | - | €310,910 | - |
| Cash at bank and in hand54/58 | €162,340 | €263,574 | €96,659 | €215,740 | ▲ 123% |
| Deferred charges and accrued income490/1 | - | - | €188,352 | €164,056 | ▼ 12.9% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €1.4m | €1.4m | €1.3m | €1.3m | ▲ 1.5% |
| Equity10/15 | €441,315 | €533,302 | €700,773 | €561,113 | ▼ 19.9% |
| Contributions10/11 | €6,200 | €6,200 | €6,199 | €6,200 | = |
| Reserves13 | €124,347 | €124,347 | €124,347 | €124,347 | = |
| Tax-exempt reserves132 | - | - | €124,347 | €124,347 | = |
| Profit (loss) carried forward14 | €310,769 | €402,756 | €570,227 | €430,567 | ▼ 24.5% |
| Amounts payable17/49 | €938,646 | €863,685 | €588,155 | €746,780 | ▲ 27.0% |
| Amounts payable after more than one year17 | €542,356 | €388,721 | €166,915 | €327,640 | ▲ 96.3% |
| Financial debts170/4 | - | - | €166,915 | €327,640 | ▲ 96.3% |
| Amounts payable within one year42/48 | €396,290 | €474,964 | €421,240 | €419,141 | ▼ 0.5% |
| Current portion of amounts payable after more than one year42 | - | - | €96,006 | €43,062 | ▼ 55.1% |
| Financial debts43 | - | - | €1,472 | €1,472 | = |
| Other loans439 | - | - | €1,472 | €1,472 | = |
| Trade debts44 | €20,908 | €9,449 | €2,187 | €9,081 | ▲ 315% |
| Suppliers440/4 | - | - | €2,187 | €9,081 | ▲ 315% |
| Taxes, remuneration and social security45 | - | - | €31,708 | €36,043 | ▲ 13.7% |
| Taxes450/3 | - | - | €31,708 | €36,043 | ▲ 13.7% |
| Other amounts payable47/48 | - | - | €289,867 | €329,483 | ▲ 13.7% |
| Line | 2018 | 2019 | 2021 | 2022 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €111,912 | €91,987 | €148,052 | -€137,248 | ▼ 193% |
| + Depreciation and write-downs630 | €139,393 | €141,373 | €142,127 | €141,367 | ▼ 0.5% |
| Operating cash flow (approximation) | €251,305 | €233,360 | €290,179 | €4,119 | ▼ 98.6% |
| Investment in fixed assets (approximation) | - | -€62,364 | - | €245,362 | - |
| Change in cash | - | €101,234 | - | €119,081 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
19-11
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 140 days late
2023
18-12
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 140 days late
2022
31-12
Financial
Weakest financial yearnet -€137,248
Net result drops to -€137,248, the lowest in the series.
31-12
Financial
Liquidity doublescurrent ratio 1.65
Current ratio from 0.68 to 1.65; short-term debt falls from €421,240 to €419,141.
19-12
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 141 days late
2021
31-12
Financial
Highest result since 2018net €148,052 ▲60.9%
Operating result €220,368, net result €148,052, both a record.
2020
24-12
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 146 days late
2019
31-12
Financial
Equity above €500,000Eq €533,302 ▲20.8%
2 profitable years in a row build equity to €533,302.
31-12
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 153 days late
2018
31-10
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 92 days late
2017
15-12
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 137 days late
2015
30-12
NBB filing
Annual accounts filed
fiscal year 2014 · full schema · 152 days late
2014
22-09
NBB filing
Annual accounts filed
fiscal year 2013 · full schema · 53 days late
2013
25-01
NBB filing
Annual accounts filed
fiscal year 2011 · full schema · 178 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Vorst · 2 establishment units since 2001
Ground area
1,087 m²
Building footprint
656 m²
Volume, LiDAR
8,335 m³
2 parcels, Brussels · tallest building 25.1 m, ±4 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
2 establishment units
Albertlaan 252, 1190 Vorst
since 20012.228.635.970
Meyerbeerstraat 24, 1190 Vorst
since 20012.228.636.465
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21383B0161/00L000 | Brussels | 961 m² | 1 · 546 m² | 25.1 m · 4 fl. |
| 21383B0129/00A000 | Brussels | 126 m² | 1 · 110 m² | 16.6 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
2549009ZET9J3S45ZT78
Similar companies · same sector, comparable size
Dr. DE BLOCK
BE 0672.588.595
Londerzeel · Eq €561,235
Dr. Carl Verdonck, Oogarts
BE 0881.863.325
Antwerpen · Eq €561,304
Aeris Medical
BE 0451.105.824
Steenokkerzeel · Eq €560,821
Dr. FG & Dr. JVG
BE 0795.119.886
Nazareth-De Pinte · Eq €560,713
DR. FRANK LIPPENS MAXFAC
BE 0819.680.682
Gent · Eq €560,706
Of 16,627 companies in sector 86220 we hold annual accounts for 7,988. 6,351 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded01-12-2000
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Contact
E-mail
vincent.robert@skynet.beVorst
Phone
02 344 00 16Vorst
Phone
02 346 63 12Vorst
E-invoicing
Reachable via Peppol
Peppol ID
0208:0473402263
Also
9925:BE0473402263
Registered
17-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.